LIPOCINE INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
LIPOCINE INC. (LPCN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-10
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-06-30 was -$465.00.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-03-31 was -$482.00.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2012-06-30 was -$9.18K.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2012-03-31 was -$722.00.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.80M, a 460.00% increase from fiscal 2024.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $500.00K, a 73.68% decline from fiscal 2023.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.90M, a 34.48% decline from fiscal 2022.
- LIPOCINE INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $2.90M, a 415.10% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $2.80M 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $500.00K 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $1.90M 10-K · filed 2025-03-13 | |||
| 2022-12-31 | $2.90M 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $563.00K 10-K · filed 2023-03-10 | $500.00K 10-K · filed 2022-03-09 | ||
| 2020-12-31 | $5.20M 10-K · filed 2022-03-09 | |||
| 2019-12-31 | $3.80M 10-K · filed 2021-03-11 | |||
| 2018-12-31 | $2.70M 10-K · filed 2020-03-13 | |||
| 2017-12-31 | $5.10M 10-K · filed 2019-03-06 | |||
| 2016-12-31 | $7.70M 10-K · filed 2018-03-12 | |||
| 2015-12-31 | $7.30M 10-K · filed 2017-03-06 | |||
| 2014-12-31 | $9.20M 10-K · filed 2016-03-10 | |||
| 2013-12-31 | $41.00K 10-K · filed 2015-03-11 | |||
| 2013-06-30 | -$465.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09 | -$947.00 10-Q · filed 2013-07-09 | ||
| 2013-03-31 | -$482.00 10-Q · filed 2013-04-24 | |||
| 2012-12-31 | -$1.50M 10-K · filed 2014-03-31 | -$11.50K 10-K · filed 2013-02-26 | ||
| 2012-06-30 | -$9.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-09 | -$9.91K 10-Q · filed 2013-07-09 | ||
| 2012-03-31 | -$722.00 10-Q · filed 2013-04-24 | |||
| 2011-12-31 | -$774.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |